FLAVONOL-SINAPIC ACID REACTION PRODUCT FOR CARDIOVASCULAR DISEASE PREVENTIVE/THERAPEUTIC EFFECTS

FLAVONOL-SINAPIC ACID REACTION PRODUCT FOR CARDIOVASCULAR DISEASE PREVENTIVE/THERAPEUTIC EFFECTS

PROBLEM TO BE SOLVED: To provide novel apolipoprotein B (ApoB100) secretion inhibitors, dyslipidemia preventive/therapeutic agents, hypercholesterolemia preventive/therapeutic agents and arteriosclerosis preventive agents containing novel flavonol-sinapic acid reaction products exhibiting ApoB100 an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MATSUI TAKEKI, YAMADA YASUMASA, MATSUKAWA TAIJI, DOI SATOSHI, KUZUMI AKINOBU, HAZA YOSHIMI, YAMADA ICHIRO
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MATSUI TAKEKI
YAMADA YASUMASA
MATSUKAWA TAIJI
DOI SATOSHI
KUZUMI AKINOBU
HAZA YOSHIMI
YAMADA ICHIRO
description PROBLEM TO BE SOLVED: To provide novel apolipoprotein B (ApoB100) secretion inhibitors, dyslipidemia preventive/therapeutic agents, hypercholesterolemia preventive/therapeutic agents and arteriosclerosis preventive agents containing novel flavonol-sinapic acid reaction products exhibiting ApoB100 antisecretory action as an active ingredient.SOLUTION: Apolipoprotein B (ApoB100) secretion inhibitors, dyslipidemia preventive/therapeutic agents, hypercholesterolemia preventive/therapeutic agents and arteriosclerosis preventive agents contain one or more compounds selected from the group consisting of flavonol-sinapic acid reaction products shown by Figure 1 and their pharmacologically acceptable salts.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2014148472A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2014148472A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2014148472A3</originalsourceid><addsrcrecordid>eNqNzLEKwjAQgOEuDqK-Q3Av2lrQ9bhc6ElJQnLNWovESbRQ3x87-ABO__Lxr4ub6SA567oysgXPqABZq0CAws4qH5zuUZRxQSEEzS5BxL6DoDRHgkgLoURWONFBWgrgqZflQ8YQStwWq8f4nPPu102xNyTYlnl6D3mexnt-5c9w9fWxaqrm0pxrOP2FvhZoNEY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FLAVONOL-SINAPIC ACID REACTION PRODUCT FOR CARDIOVASCULAR DISEASE PREVENTIVE/THERAPEUTIC EFFECTS</title><source>esp@cenet</source><creator>MATSUI TAKEKI ; YAMADA YASUMASA ; MATSUKAWA TAIJI ; DOI SATOSHI ; KUZUMI AKINOBU ; HAZA YOSHIMI ; YAMADA ICHIRO</creator><creatorcontrib>MATSUI TAKEKI ; YAMADA YASUMASA ; MATSUKAWA TAIJI ; DOI SATOSHI ; KUZUMI AKINOBU ; HAZA YOSHIMI ; YAMADA ICHIRO</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide novel apolipoprotein B (ApoB100) secretion inhibitors, dyslipidemia preventive/therapeutic agents, hypercholesterolemia preventive/therapeutic agents and arteriosclerosis preventive agents containing novel flavonol-sinapic acid reaction products exhibiting ApoB100 antisecretory action as an active ingredient.SOLUTION: Apolipoprotein B (ApoB100) secretion inhibitors, dyslipidemia preventive/therapeutic agents, hypercholesterolemia preventive/therapeutic agents and arteriosclerosis preventive agents contain one or more compounds selected from the group consisting of flavonol-sinapic acid reaction products shown by Figure 1 and their pharmacologically acceptable salts.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140821&amp;DB=EPODOC&amp;CC=JP&amp;NR=2014148472A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140821&amp;DB=EPODOC&amp;CC=JP&amp;NR=2014148472A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MATSUI TAKEKI</creatorcontrib><creatorcontrib>YAMADA YASUMASA</creatorcontrib><creatorcontrib>MATSUKAWA TAIJI</creatorcontrib><creatorcontrib>DOI SATOSHI</creatorcontrib><creatorcontrib>KUZUMI AKINOBU</creatorcontrib><creatorcontrib>HAZA YOSHIMI</creatorcontrib><creatorcontrib>YAMADA ICHIRO</creatorcontrib><title>FLAVONOL-SINAPIC ACID REACTION PRODUCT FOR CARDIOVASCULAR DISEASE PREVENTIVE/THERAPEUTIC EFFECTS</title><description>PROBLEM TO BE SOLVED: To provide novel apolipoprotein B (ApoB100) secretion inhibitors, dyslipidemia preventive/therapeutic agents, hypercholesterolemia preventive/therapeutic agents and arteriosclerosis preventive agents containing novel flavonol-sinapic acid reaction products exhibiting ApoB100 antisecretory action as an active ingredient.SOLUTION: Apolipoprotein B (ApoB100) secretion inhibitors, dyslipidemia preventive/therapeutic agents, hypercholesterolemia preventive/therapeutic agents and arteriosclerosis preventive agents contain one or more compounds selected from the group consisting of flavonol-sinapic acid reaction products shown by Figure 1 and their pharmacologically acceptable salts.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzLEKwjAQgOEuDqK-Q3Av2lrQ9bhc6ElJQnLNWovESbRQ3x87-ABO__Lxr4ub6SA567oysgXPqABZq0CAws4qH5zuUZRxQSEEzS5BxL6DoDRHgkgLoURWONFBWgrgqZflQ8YQStwWq8f4nPPu102xNyTYlnl6D3mexnt-5c9w9fWxaqrm0pxrOP2FvhZoNEY</recordid><startdate>20140821</startdate><enddate>20140821</enddate><creator>MATSUI TAKEKI</creator><creator>YAMADA YASUMASA</creator><creator>MATSUKAWA TAIJI</creator><creator>DOI SATOSHI</creator><creator>KUZUMI AKINOBU</creator><creator>HAZA YOSHIMI</creator><creator>YAMADA ICHIRO</creator><scope>EVB</scope></search><sort><creationdate>20140821</creationdate><title>FLAVONOL-SINAPIC ACID REACTION PRODUCT FOR CARDIOVASCULAR DISEASE PREVENTIVE/THERAPEUTIC EFFECTS</title><author>MATSUI TAKEKI ; YAMADA YASUMASA ; MATSUKAWA TAIJI ; DOI SATOSHI ; KUZUMI AKINOBU ; HAZA YOSHIMI ; YAMADA ICHIRO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2014148472A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MATSUI TAKEKI</creatorcontrib><creatorcontrib>YAMADA YASUMASA</creatorcontrib><creatorcontrib>MATSUKAWA TAIJI</creatorcontrib><creatorcontrib>DOI SATOSHI</creatorcontrib><creatorcontrib>KUZUMI AKINOBU</creatorcontrib><creatorcontrib>HAZA YOSHIMI</creatorcontrib><creatorcontrib>YAMADA ICHIRO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MATSUI TAKEKI</au><au>YAMADA YASUMASA</au><au>MATSUKAWA TAIJI</au><au>DOI SATOSHI</au><au>KUZUMI AKINOBU</au><au>HAZA YOSHIMI</au><au>YAMADA ICHIRO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FLAVONOL-SINAPIC ACID REACTION PRODUCT FOR CARDIOVASCULAR DISEASE PREVENTIVE/THERAPEUTIC EFFECTS</title><date>2014-08-21</date><risdate>2014</risdate><abstract>PROBLEM TO BE SOLVED: To provide novel apolipoprotein B (ApoB100) secretion inhibitors, dyslipidemia preventive/therapeutic agents, hypercholesterolemia preventive/therapeutic agents and arteriosclerosis preventive agents containing novel flavonol-sinapic acid reaction products exhibiting ApoB100 antisecretory action as an active ingredient.SOLUTION: Apolipoprotein B (ApoB100) secretion inhibitors, dyslipidemia preventive/therapeutic agents, hypercholesterolemia preventive/therapeutic agents and arteriosclerosis preventive agents contain one or more compounds selected from the group consisting of flavonol-sinapic acid reaction products shown by Figure 1 and their pharmacologically acceptable salts.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JP2014148472A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title FLAVONOL-SINAPIC ACID REACTION PRODUCT FOR CARDIOVASCULAR DISEASE PREVENTIVE/THERAPEUTIC EFFECTS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T10%3A37%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MATSUI%20TAKEKI&rft.date=2014-08-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2014148472A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true